Page last updated: 2024-10-25

ciglitazone and Hyperglycemia, Postprandial

ciglitazone has been researched along with Hyperglycemia, Postprandial in 7 studies

ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.

Hyperglycemia, Postprandial: Abnormally high BLOOD GLUCOSE level after a meal.

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19902 (28.57)18.7374
1990's3 (42.86)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clark, DA1
Goldstein, SW1
Volkmann, RA1
Eggler, JF1
Holland, GF1
Hulin, B1
Stevenson, RW1
Kreutter, DK1
Gibbs, EM1
Krupp, MN1
Wrobel, J1
Li, Z1
Dietrich, A1
McCaleb, M1
Mihan, B1
Sredy, J1
Sullivan, D1
Fujisawa, K1
Nishikawa, T1
Kukidome, D1
Imoto, K1
Yamashiro, T1
Motoshima, H1
Matsumura, T1
Araki, E1
Mishra, PK1
Tyagi, N1
Sen, U1
Joshua, IG1
Tyagi, SC1
Yen, TT1
Gill, AM1
Powell, JG1
Sampson, BM1
Chang, AY1
Wyse, BM2
Diani, AR1
Sawada, GA1

Other Studies

7 other studies available for ciglitazone and Hyperglycemia, Postprandial

ArticleYear
Substituted dihydrobenzopyran and dihydrobenzofuran thiazolidine-2,4-diones as hypoglycemic agents.
    Journal of medicinal chemistry, 1991, Volume: 34, Issue:1

    Topics: Adipose Tissue; Animals; Benzofurans; Biological Transport, Active; Cell Line; Deoxyglucose; Hypergl

1991
Novel 5-(3-aryl-2-propynyl)-5-(arylsulfonyl)thiazolidine-2,4-diones as antihyperglycemic agents.
    Journal of medicinal chemistry, 1998, Mar-26, Volume: 41, Issue:7

    Topics: Animals; Blood Glucose; Hyperglycemia; Hypoglycemic Agents; Male; Mice; Mice, Inbred C57BL; Rats; Ra

1998
TZDs reduce mitochondrial ROS production and enhance mitochondrial biogenesis.
    Biochemical and biophysical research communications, 2009, Jan-30, Volume: 379, Issue:1

    Topics: Cells, Cultured; DNA, Mitochondrial; Heat-Shock Proteins; Humans; Hyperglycemia; Hypoglycemic Agents

2009
Synergism in hyperhomocysteinemia and diabetes: role of PPAR gamma and tempol.
    Cardiovascular diabetology, 2010, Sep-09, Volume: 9

    Topics: Animals; Antioxidants; Cardiomyopathies; Cyclic N-Oxides; Diabetes Complications; Diabetes Mellitus,

2010
Ciglitazone prevents and reverses dexamethasone-induced hyperglycemia in female viable yellow mice.
    International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity, 1992, Volume: 16, Issue:11

    Topics: Administration, Oral; Animals; Blood Glucose; Body Weight; Corticosterone; Dexamethasone; Dose-Respo

1992
The hypoglycemic effect of ciglitazone in obese, hyperglycemic animal models.
    Progress in clinical and biological research, 1988, Volume: 265

    Topics: Adipose Tissue; Adipose Tissue, Brown; Animals; Blood Glucose; Disease Models, Animal; Glycolysis; H

1988
A review of the effects of ciglitazone on the pancreatic islets of obese, hyperglycemic mice.
    Progress in clinical and biological research, 1988, Volume: 265

    Topics: Animals; Hyperglycemia; Hypoglycemic Agents; Insulin; Islets of Langerhans; Male; Mice; Mice, Obese;

1988